FDA — authorised 6 April 1970
- Application: NDA016860
- Marketing authorisation holder: NOVEN THERAP
- Local brand name: ESKALITH
- Indication: CAPSULE — ORAL
- Status: approved
🇺🇸 Lithium Augmentation in United States
FDA authorised Lithium Augmentation on 6 April 1970
Marketing authorisations
FDA — authorised 26 February 1979
- Application: NDA017971
- Marketing authorisation holder: JDS PHARMS
- Local brand name: ESKALITH
- Indication: TABLET — ORAL
- Status: approved
Other Psychiatry / Mental Health approved in United States
Frequently asked questions
Is Lithium Augmentation approved in United States?
Yes. FDA authorised it on 6 April 1970; FDA authorised it on 26 February 1979.
Who is the marketing authorisation holder for Lithium Augmentation in United States?
NOVEN THERAP holds the US marketing authorisation.